$23.88
0.44% today
NYSE, Apr 01, 06:21 pm CET
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Kenvue Stock price

$23.98
+0.38 1.61% 1M
+0.85 3.67% 6M
+2.63 12.32% YTD
+2.75 12.95% 1Y
-2.92 10.86% 3Y
-2.92 10.86% 5Y
-2.92 10.86% 10Y
NYSE, Closing price Mon, Mar 31 2025
+0.28 1.18%
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Key metrics

Market capitalization $45.83b
Enterprise Value $53.48b
P/E (TTM) P/E ratio 44.80
EV/FCF (TTM) EV/FCF 40.24
EV/Sales (TTM) EV/Sales 3.46
P/S ratio (TTM) P/S ratio 2.97
P/B ratio (TTM) P/B ratio 4.75
Dividend yield 3.38%
Last dividend (FY24) $0.81
Revenue growth (TTM) Revenue growth 0.08%
Revenue (TTM) Revenue $15.46b
EBIT (operating result TTM) EBIT $2.70b
Free Cash Flow (TTM) Free Cash Flow $1.33b
Cash position $1.07b
EPS (TTM) EPS $0.54
P/E forward 23.96
P/S forward 2.98
EV/Sales forward 3.47
Short interest 1.87%
Show more

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Kenvue forecast:

6x Buy
32%
13x Hold
68%

Analyst Opinions

19 Analysts have issued a Kenvue forecast:

Buy
32%
Hold
68%

Financial data from Kenvue

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
15,456 15,456
0% 0%
100%
- Direct Costs 6,496 6,496
5% 5%
42%
8,960 8,960
4% 4%
58%
- Selling and Administrative Expenses 5,228 5,228
13% 13%
34%
- Research and Development Expense 408 408
2% 2%
3%
3,324 3,324
7% 7%
22%
- Depreciation and Amortization 620 620
1% 1%
4%
EBIT (Operating Income) EBIT 2,704 2,704
9% 9%
17%
Net Profit 1,030 1,030
32% 32%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Positive
24/7 Wall Street
about 5 hours ago
If you were a big fan of “That '70s Show,” get ready because we may soon get a revival, and it will likely not be as entertaining.
Positive
Seeking Alpha
about 21 hours ago
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Neutral
PRNewsWire
one day ago
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J. , March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70.
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Thibaut Mongon
Employees 22,000
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today